Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Ataibeckley Inc (ATAI)

Ataibeckley Inc (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MarketBeat.com
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 MarketBeat - Mon Jan 19, 10:28AM CST

2026 could be a pivotal year for three biotech names, including a standout in the hemodialysis space and two emerging companies with strong pipelines.

EVMN : 28.73 (-7.62%)
ATAI : 3.82 (-3.29%)
CRMD : 7.08 (-1.26%)
Doctor holding money by IherPhoto via iStock
The 1 Riskiest Investment That Paid Off in 2025 Barchart - Thu Dec 25, 2025

Wall Street still sees triple-digit upside in this high-risk biotech bet.

ATAI : 3.82 (-3.29%)
$SPX : 6,861.89 (-0.28%)
MarketBeat.com
MarketBeat’s Top 5 Rated Small-Cap Stocks MarketBeat - Mon Dec 22, 2025

Small-cap stocks are regaining momentum as rate cuts and the end of quantitative tightening drive a renewed risk-on environment.

ATAI : 3.82 (-3.29%)
TRVI : 10.56 (+3.63%)
CRMD : 7.08 (-1.26%)
TREE : 38.39 (-2.27%)
MNMD : 15.02 (+1.01%)
IWM : 264.60 (+0.23%)
Enhanced Fortifies Executive Leadership Team & Board of Directors PR Newswire - Wed Nov 19, 2025

– Co-Founder Maximilian Martin Appointed CEO –

ATAI : 3.82 (-3.29%)
A concept image of a woman placing a psychedelic pill in her open mouth by BLACKDAY via Shutterstock_com
North Carolina Wants to ‘Lead the Nation’ in Psychedelics. Here’s 1 ‘Strong Buy’ Stock to Buy Now. Barchart - Fri Oct 24, 2025

As policy meets potential in North Carolina, Atai Life Sciences could be a solid portfolio addition now.

ATAI : 3.82 (-3.29%)
JNJ : 246.91 (+0.78%)
ATAI Life Sciences to Acquire Beckley Psytech Tipranks - Sat Oct 11, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. ATAI Life...

ATAI : 3.82 (-3.29%)
Brera Holdings (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI Investor Brand Network - Mon Sep 22, 2025

Brera Holdings (NASDAQ: BREA), which is rebranding as Solmate and pivoting to a Solana-based digital asset treasury and crypto infrastructure, surged after Cathie Wood’s ARK Invest purchased 6,500,001...

ROKU : 89.61 (-0.67%)
BREA : 25.20 (+1.94%)
AVAV : 281.67 (+6.11%)
ATAI : 3.82 (-3.29%)
BIDU : 137.11 (-0.55%)
ARCT : 7.97 (+6.13%)
PONY : 13.81 (+1.17%)
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032 GlobeNewswire - Tue Jul 1, 2025

CMPS : 8.26 (-2.25%)
CYBN.NE : 11.5800 (+4.23%)
ATAI : 3.82 (-3.29%)
MMED.NE : 14.9000 (+9.48%)
SAGE : 8.68 (-0.23%)
MNMD : 15.02 (+1.01%)
CYBN : 8.28 (+1.22%)
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032 FinancialNewsMedia - Tue Jul 1, 2025

EQNX::TICKER_START (NYSE:CYBN),(NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:SAGE),(NASDAQ:MNMD),(NASDAQ:ATAI),(NEO:MMED) EQNX::TICKER_END

CMPS : 8.26 (-2.25%)
CYBN.NE : 11.5800 (+4.23%)
ATAI : 3.82 (-3.29%)
MMED.NE : 14.9000 (+9.48%)
SAGE : 8.68 (-0.23%)
MNMD : 15.02 (+1.01%)
CYBN : 8.28 (+1.22%)
A concept image of a woman placing a psychedelic pill in her open mouth by BLACKDAY via Shutterstock_com
2 ‘Strong Buy’ Psychedelic Stocks to Scoop Up ASAP Barchart - Tue May 27, 2025

Two psychedelic-focused stocks stand to benefit after the FDA designated psychedelics as a top review priority.

ATAI : 3.82 (-3.29%)
MNMD : 15.02 (+1.01%)

Barchart Exclusives

Kraft Heinz Pauses Its Breakup Plans. Should You Buy the High-Yield Dividend Stock Here? Barchart - 34 minutes ago
Kraft Heinz is still facing many tough challenges. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot